NEW YORK (GenomeWeb) – Quest Diagnostics said late on Thursday that it has received US Food and Drug Administration Emergency Use Authorization for the Zika Virus RNA Qualitative Real-Time RT-PCR test.

The assay, developed by the reference laboratory business of Quest's Focus Diagnostics subsidiary, is intended for the qualitative detection of Zika virus RNA in human serum specimens from certain individuals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.